Jean-Max Demiautte is an Analyst at TechLife Capital.
He started as a pharmacist at the hospital in various departments such as nuclear medicine, infectious diseases and central pharmacy.
He then worked in the industry, focusing on quality assurance systems at the unidose specialist Unither Pharmaceuticals. Subsequently, he joined Sanofi’s global medical affairs department, in charge of the group's diabetes strategy.
Jean-Max is a graduate pharmacist from the University of Amiens, specializing in the pharmaceutical industry. Additionally, he holds a Master 2 in Business Administration from IAE and an ESCP Master's degree in Biopharmaceutical Management.